Enanta Pharmaceuticals, Inc. (ENTA)
12.50
+0.40
(+3.31%)
USD |
NASDAQ |
Oct 09, 16:00
12.48
-0.02
(-0.12%)
After-Hours: 20:00
Enanta Pharmaceuticals Price : 12.50 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 12.07 | 12.61 | 12.07 | 12.50 | 182070.0 |
| Oct 08, 2026 | 12.26 | 12.35 | 11.70 | 12.10 | 282901.0 |
| Oct 07, 2026 | 12.09 | 12.57 | 12.05 | 12.37 | 191667.0 |
| Oct 06, 2026 | 12.66 | 12.66 | 11.97 | 12.17 | 271697.0 |
| Oct 05, 2026 | 12.95 | 13.02 | 12.47 | 12.60 | 218875.0 |
| Oct 02, 2026 | 13.20 | 13.21 | 12.58 | 12.96 | 748004.0 |
| Oct 01, 2026 | 13.08 | 13.45 | 12.83 | 12.84 | 331488.0 |
| Sep 30, 2026 | 12.67 | 13.41 | 12.44 | 13.18 | 425884.0 |
| Sep 29, 2026 | 12.62 | 12.85 | 12.43 | 12.64 | 322821.0 |
| Sep 28, 2026 | 11.88 | 12.68 | 11.69 | 12.62 | 349328.0 |
| Sep 25, 2026 | 11.99 | 12.00 | 11.64 | 11.88 | 217317.0 |
| Sep 24, 2026 | 11.94 | 12.02 | 11.67 | 12.00 | 206241.0 |
| Sep 23, 2026 | 12.33 | 12.33 | 11.87 | 11.95 | 206322.0 |
| Sep 22, 2026 | 12.24 | 12.47 | 12.03 | 12.42 | 164646.0 |
| Sep 21, 2026 | 12.28 | 12.28 | 11.94 | 12.11 | 217213.0 |
| Sep 18, 2026 | 12.49 | 12.60 | 12.19 | 12.20 | 428245.0 |
| Sep 17, 2026 | 12.67 | 12.84 | 12.48 | 12.52 | 277683.0 |
| Sep 16, 2026 | 12.33 | 12.92 | 12.33 | 12.70 | 267530.0 |
| Sep 15, 2026 | 13.07 | 13.07 | 12.16 | 12.29 | 284879.0 |
| Sep 14, 2026 | 12.81 | 13.13 | 12.79 | 13.12 | 280241.0 |
| Sep 11, 2026 | 12.83 | 13.04 | 12.59 | 12.96 | 289137.0 |
| Sep 10, 2026 | 13.09 | 13.21 | 12.44 | 12.70 | 312792.0 |
| Sep 09, 2026 | 13.50 | 13.51 | 13.09 | 13.24 | 192953.0 |
| Sep 08, 2026 | 13.91 | 13.91 | 13.43 | 13.50 | 158196.0 |
| Sep 04, 2026 | 13.92 | 14.22 | 13.45 | 14.08 | 233451.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Perspective Therapeutics, Inc. | 2.66 |
| Coherus Oncology, Inc. | 1.07 |
| BridgeBio Pharma, Inc. | 65.35 |
| RenovoRx, Inc. | 1.28 |
| ACADIA Pharmaceuticals, Inc. | 19.78 |
Price Related Metrics
| PS Ratio | 5.184 |
| Price to Book Value | 3.602 |
| Earnings Yield | -19.29% |
| Market Cap | 364.00M |